Table S1.
Clinical outcomes for all patients undergoing rFSH stimulation using either Gonal-f or Puregon
| Gonal-f (±SD) | Puregon (±SD) | P-value | |
|---|---|---|---|
| Mean age (years) | 35.9 (±5.2) | 36.4 (±5.4) | 0.012* |
| Mean BMI (kg/m2) | 24.4 (±4.4) | 24.9 (±4.5) | 0.003** |
| Mean eggs collected | 9.1 (±5.7) | 8.3 (±5.7) | 0.0003*** |
| Mean 2PN generated | 5.1 (±4.0) | 4.7 (±3.9) | 0.009** |
| Mean oocyte utilization (%) | 33.3 (±23.6) | 34.0 (±24.3) | 0.453 |
| Mean embryo utilization (%) | 55.3 (±32.4) | 57.8 (±36.7) | 0.063 |
| Clinical pregnancy rate per fresh ET (%) | 28.2 | 28.4 | 0.945 |
| Live birth rate per fresh ET (%) | 22.8 | 22.4 | 0.838 |
| Miscarriage rate per pregnancy (%) | 19.0 | 21.2 | 0.551 |
Notes: No significant differences were observed for pregnancy, birth, or miscarriage rates. However, the populations were slightly but significantly different in terms of mean age, mean BMI, and the number of oocytes and embryos with 2PN retrieved.
*
P<0.05,
**
P<0.01,
***
P<0.001.
Abbreviations: 2PN, two pronuclei; BMI, body mass index; ET, embryo transfer; rFSH, recombinant follicle stimulating hormone; SD, standard deviation.